Microbial Identification for Clinical Laboratories (IVD-CE)

MBT Subtyping IVD Module

Fast microorganism identification combined with instant typing

MBT Subtyping IVD Module

The MBT Subtyping IVD Module combines the identification of important pathogens with automated subsequent detection of specific marker peaks, all in one workflow. The superb discriminatory power of Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight (MALDI-TOF) mass spectrometry allows for the accurate and fast identification of thousands of microorganism species, while powerful software automatically performs instant typing and result reporting. 

Differentiation of closely related species

Bruker’s MALDI Biotyper® has revolutionized microorganism identification over the past decade. Its high discriminatory power allows for identification of thousands of different species, but there are some genera still difficult to differentiate. The MBT Subtyping IVD Module enables the automated detection of specific marker peaks, and provides confidence in microbial identification.

Bruker developed the MBT Subtyping IVD Module to overcome differentiation hurdles in microorganism identification, which now allows for automated differentiation of Mycobacterium chimaera from Mycobacterium intracellulare. This differentiation supports further insights into the pathogenic role of M. chimaera.

Detecting resistance markers

Antibiotic resistant bacteria are on the rise and effective prevention and control is therefore of high importance in healthcare. MALDI-TOF mass spectrometry has the potential to identify specific resistance markers, and the MBT Subtyping IVD Module provides a warning about a potential resistance. It combines the identification of important pathogens with automated subsequent detection of specific resistance markers in one automated workflow.

Available now, as an early warning system, is the quick detection of blaKPC expressing K. pneumoniae and E. coli, and cfiA positive/negative B. fragilis strains.

No additional sample preparation

To acquire a typing result, no additional sample preparation is required once the samples are directly transferred to MALDI target plates. When the bacterium has been identified, the software automatically performs the typing and result reporting, ensuring efficient laboratory practice and rapid time-to-result.


Please contact your local representative for availability in your country.

Not for sale in the USA.

As of May 2021, Bruker Daltonik GmbH is now Bruker Daltonics GmbH & Co. KG.

Related products